{
    "2018-01-20": [
        [
            {
                "time": "",
                "original_text": "谨防年报预告业绩“变脸”雷区",
                "features": {
                    "keywords": [
                        "年报",
                        "预告",
                        "业绩",
                        "变脸",
                        "雷区"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "布局年报的绩优股 谨防预告业绩“变脸”雷区",
                "features": {
                    "keywords": [
                        "布局",
                        "年报",
                        "绩优股",
                        "预告",
                        "业绩",
                        "变脸",
                        "雷区"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物“对赌局”巨亏溯源",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "对赌局",
                        "巨亏",
                        "溯源"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物大股东悄撤离:云南工投20亿接棒 估值涨6倍",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "大股东",
                        "撤离",
                        "云南工投",
                        "接棒",
                        "估值",
                        "涨6倍"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}